Sanofi’s Rilzabrutinib Approved in China: First BTK Inhibitor for Immune Thrombocytopenia (ITP)
On September 3, 2026, China’s NMPA website showed that Sanofi’s rilzabrutinib tablets had been approved…
Articles
Rare Disease Drugs in China: 6 Innovative Medicines Approved in H1 2026 and Their Indications
In the first half of 2026, the field of rare disease drugs in China continued…
Innovative Lung Cancer Drug Asandeutertinib Approved: Deuterated Third-Generation EGFR-TKI for Brain Metastases
Treatment options for EGFR-mutated lung cancer continue to expand, but for patients with central nervous…
How China Online Pharmacies Work: Online-Offline Integration and Global User Services
Key Takeaways As international interest in Chinese medicines and pharmaceutical resources continues to grow, finding…
Innovative Plaque Psoriasis Drug Lecankitug Approved: The World’s Second IL-17A/F Dual-Target Drug
The psoriasis biologics market is gradually moving from single-target competition toward more differentiated mechanism-based competition.…
What Medicines Can Be Sourced from China? A Guide for B2B Pharmaceutical Buyers
China has a large and well-established pharmaceutical research, manufacturing, and supply system, making it an…
How to Find a Pharmacy in China: A Complete Guide for Expats and Visitors
If you are traveling, working, studying, or living in China, knowing how to find a…
The Smart Buyer’s Guide to Buy Medicine in China: Quality, Value & Supply Chain Insights
With its pharmaceutical innovation engine roaring, China has become a premier destination to buy medicine in…
Chinese Drugstore Online at the Heart of China’s Pharmaceutical Metamorphosis
Gone are the days of waiting in long queues at hospitals or visiting local drugstores…
Innovative Multiple Myeloma Drug Velinotamig Approved in China for R/R Patients After Multiple Lines of Treatment
Multiple myeloma (MM) is a malignant tumor of plasma cells. Although treatment options have expanded…